{{isShortDescriptionLonger && !showFullDescription ? shortDescription.slice(0, 250) : shortDescription}}... See {{showFullDescription? 'less' : 'more'}}
Epstein Barr Virus Reactivation in COVID
A study from China published in May 2021 concluded: We find a high incidence of EBV coinfection in COVID-19 patients. EBV/SARS-CoV-2 coinfection was associated with fever and increased inflammation. EBV reactivation may be associated with the severity of COVID-19. The reactivation of EBV may also be the cause of the COVID long haul symptoms. Let's review.
About infectious Mononucleosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670567/
Study published in nature on May 21st 2021
https://www.nature.com/articles/s41598-021-90351-y
No credit card information needed.
Write A New Comment
0 Comments